Adamek RJ et al. |
Modified short-term triple therapy--ranitidine, clarithromycin, and metronidazole--for cure of Helicobacter pylori infection. |
1995 |
Am. J. Gastroenterol. |
pmid:7801936
|
Gisbert JP et al. |
Esomeprazole-based therapy in Helicobacter pylori eradication: any effect by increasing the dose of esomeprazole or prolonging the treatment? |
2005 |
Am. J. Gastroenterol. |
pmid:16128936
|
Sontag SJ et al. |
Reduced symptoms and need for antisecretory therapy in veterans 3 years after Helicobacter pylori eradication with ranitidine bismuth citrate/amoxicillin/clarithromycin. |
2001 |
Am. J. Gastroenterol. |
pmid:11374672
|
Kume K et al. |
Disappearance of both MALT lymphoma and hyperplastic polyps in the stomach after eradication of Helicobacter pylori. |
2001 |
Am. J. Gastroenterol. |
pmid:11569719
|
Savarino V et al. |
What is the meaning of ranitidine in successful triple-therapy against Helicobacter pylori infection? |
1995 |
Am. J. Gastroenterol. |
pmid:8540537
|
Gisbert JP et al. |
Response to article by Forné et al. |
1996 |
Am. J. Gastroenterol. |
pmid:8561132
|
Cremonini F et al. |
Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study. |
2002 |
Am. J. Gastroenterol. |
pmid:12425542
|
Nista EC et al. |
Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication. |
2006 |
Am. J. Gastroenterol. |
pmid:16968503
|
van Zanten SV and Thompson K |
Should the presence of polymorphisms of CYP2C19 enzymes influence the choice of the proton pump inhibitor for treatment of Helicobacter pylori infection? |
2006 |
Am. J. Gastroenterol. |
pmid:16863548
|
Froehlich F et al. |
Helicobacter pylori eradication treatment does not benefit patients with nonulcer dyspepsia. |
2001 |
Am. J. Gastroenterol. |
pmid:11513170
|
Sugimoto M et al. |
Prevention of hemorrhage from intradiverticular ulcer in the duodenum by Helicobacter pylori eradication. |
2000 |
Am. J. Gastroenterol. |
pmid:10685780
|
Coelho LG et al. |
Once-daily Helicobacter pylori treatment to family members of gastric cancer patients. |
2000 |
Am. J. Gastroenterol. |
pmid:10710099
|
Pilotto A et al. |
In vitro activity of rifabutin against strains of Helicobacter pylori resistant to metronidazole and clarithromycin. |
2000 |
Am. J. Gastroenterol. |
pmid:10710100
|
Hansen JM et al. |
Effect of a community screening for Helicobacter pylori: a 5-Yr follow-up study. |
2008 |
Am. J. Gastroenterol. |
pmid:18445098
|
Watson JB and Moss SF |
Will H. pylori stagger under the weight of this LOAD? A novel but expensive eradication regimen. |
2011 |
Am. J. Gastroenterol. |
pmid:22056576
|
Lazzaroni M et al. |
Triple therapy with ranitidine or lansoprazole in the treatment of Helicobacter pylori-associated duodenal ulcer. |
1997 |
Am. J. Gastroenterol. |
pmid:9128316
|
van der Hulst RW et al. |
Therapeutic options after failed Helicobacter pylori eradication therapy. |
1996 |
Am. J. Gastroenterol. |
pmid:8931413
|
Alder JD et al. |
Relevance of the ferret model of Helicobacter-induced gastritis to evaluation of antibacterial therapies. |
1996 |
Am. J. Gastroenterol. |
pmid:8931416
|
Levy M et al. |
Conservative treatment of primary gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue: predictive factors of response and outcome. |
2002 |
Am. J. Gastroenterol. |
pmid:11866264
|
Christopher K et al. |
Clarithromycin use preceding fulminant hepatic failure. |
2002 |
Am. J. Gastroenterol. |
pmid:11866297
|
Narayani RI et al. |
Resolution of collagenous colitis after treatment for Helicobacter pylori. |
2002 |
Am. J. Gastroenterol. |
pmid:11866305
|
Gisbert JP et al. |
Third-line rescue therapy with levofloxacin after two H. pylori treatment failures. |
2006 |
Am. J. Gastroenterol. |
pmid:16454825
|
Stack WA et al. |
Safety and efficacy of rabeprazole in combination with four antibiotic regimens for the eradication of Helicobacter pylori in patients with chronic gastritis with or without peptic ulceration. |
1998 |
Am. J. Gastroenterol. |
pmid:9772054
|
Adamek RJ and Bethke TD |
Cure of Helicobacter pylori infection and healing of duodenal ulcer: comparison of pantoprazole-based one-week modified triple therapy versus two-week dual therapy. The International Pantoprazole HP Study Group. |
1998 |
Am. J. Gastroenterol. |
pmid:9772056
|
Fennerty MB |
Should we abandon metronidazole containing Helicobacter pylori treatment regimens? The clinical relevance of metronidazole resistance. |
1998 |
Am. J. Gastroenterol. |
pmid:9448162
|
Forné M et al. |
Randomized clinical trial comparing two one-week triple-therapy regimens for the eradication of Helicobacter pylori infection and duodenal ulcer healing. |
1998 |
Am. J. Gastroenterol. |
pmid:9448170
|
Hsu PI et al. |
A prospective randomized trial of esomeprazole- versus pantoprazole-based triple therapy for Helicobacter pylori eradication. |
2005 |
Am. J. Gastroenterol. |
pmid:16279889
|
Vakil N |
Helicobacter pylori: factors affecting eradication and recurrence. |
2005 |
Am. J. Gastroenterol. |
pmid:16279890
|
Labenz J and Börsch G |
Toward an optimal treatment of Helicobacter pylori-positive peptic ulcers. |
1995 |
Am. J. Gastroenterol. |
pmid:7733070
|
Forné M et al. |
Impact of colloidal bismuth subnitrate in the eradication rates of Helicobacter pylori infection-associated duodenal ulcer using a short treatment regimen with omeprazole and clarithromycin: a randomized study. |
1995 |
Am. J. Gastroenterol. |
pmid:7733075
|
Giannini E et al. |
Influence of Helicobacter pylori eradication therapy on 13C aminopyrine breath test: comparison among omeprazole-, lansoprazole-, or pantoprazole-containing regimens. |
2000 |
Am. J. Gastroenterol. |
pmid:11051345
|
Vakil N and Cutler A |
Ten-day triple therapy with ranitidine bismuth citrate, amoxicillin, and clarithromycin in eradicating Helicobacter pylori. |
1999 |
Am. J. Gastroenterol. |
pmid:10235192
|
Trevisani L et al. |
A four-day low dose triple therapy regimen for the treatment of Helicobacter pylori infection. |
1998 |
Am. J. Gastroenterol. |
pmid:9517646
|
Zullo A et al. |
Omeprazole plus clarithromycin and either tinidazole or tetracycline for Helicobacter pylori infection: a randomized prospective study. |
1997 |
Am. J. Gastroenterol. |
pmid:9362185
|
Kawasaki M et al. |
Ménétrièr's disease associated with Helicobacter pylori infection: resolution of enlarged gastric folds and hypoproteinemia after antibacterial treatment. |
1997 |
Am. J. Gastroenterol. |
pmid:9382064
|
Adamek RJ et al. |
Pantoprazole versus omeprazole in one-week low-dose triple therapy for curve of H. pylori infection. |
1997 |
Am. J. Gastroenterol. |
pmid:9382084
|
Murata H et al. |
Evaluation of the PyloriTek test for detection of Helicobacter pylori infection in cases with and without eradication therapy. |
1998 |
Am. J. Gastroenterol. |
pmid:9820380
|
Laine L et al. |
Twice-daily, 10-day triple therapy with omeprazole, amoxicillin, and clarithromycin for Helicobacter pylori eradication in duodenal ulcer disease: results of three multicenter, double-blind, United States trials. |
1998 |
Am. J. Gastroenterol. |
pmid:9820381
|
Calvet X et al. |
Seven versus ten days of rabeprazole triple therapy for Helicobacter pylori eradication: a multicenter randomized trial. |
2005 |
Am. J. Gastroenterol. |
pmid:16086704
|
Vakil N and Fennerty MB |
Cost-effectiveness of treatment regimens for the eradication of Helicobacter pylori in duodenal ulcer. |
1996 |
Am. J. Gastroenterol. |
pmid:8607487
|
Treiber G |
The influence of drug dosage on Helicobacter pylori eradication: a cost-effectiveness analysis. |
1996 |
Am. J. Gastroenterol. |
pmid:8607488
|
Bardhan KD et al. |
Ranitidine bismuth citrate with clarithromycin given twice daily effectively eradicates Helicobacter pylori and heals duodenal ulcers. |
1998 |
Am. J. Gastroenterol. |
pmid:9517644
|
Adamek RJ et al. |
Primary and acquired Helicobacter pylori resistance to clarithromycin, metronidazole, and amoxicillin--influence on treatment outcome. |
1998 |
Am. J. Gastroenterol. |
pmid:9517645
|
Vakil N |
Helicobacter pylori treatment: a practical approach. |
2006 |
Am. J. Gastroenterol. |
pmid:16542285
|
Fuccio L et al. |
Can sequential therapy for Helicobacter pylori eradication overcome clarithromycin resistance?: Data still do not support conclusions. |
2010 |
Am. J. Gastroenterol. |
pmid:20606668
|
Nakao K et al. |
Relation of lactoferrin levels in gastric mucosa with Helicobacter pylori infection and with the degree of gastric inflammation. |
1997 |
Am. J. Gastroenterol. |
pmid:9177520
|
Maconi G et al. |
Do some patients with Helicobacter pylori infection benefit from an extension to 2 weeks of a proton pump inhibitor-based triple eradication therapy? |
2001 |
Am. J. Gastroenterol. |
pmid:11232676
|
Laine L et al. |
Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori. |
1997 |
Am. J. Gastroenterol. |
pmid:9399755
|
Luther J et al. |
Empiric quadruple vs. triple therapy for primary treatment of Helicobacter pylori infection: Systematic review and meta-analysis of efficacy and tolerability. |
2010 |
Am. J. Gastroenterol. |
pmid:19755966
|
Chey WD et al. |
ACG Clinical Guideline: Treatment of Helicobacter pylori Infection. |
2017 |
Am. J. Gastroenterol. |
pmid:28071659
|